Options market data indicates bullish bets on drug stock price appreciation for AbbVie (ABBV), now trading at $168. Mark Cuban gave Trump's new drugstore venture a "B," and said it would be good for patients. In the latest trading session, AbbVie (ABBV) closed at $236.56, marking a -3.2% move from the previous day. The stock's change was less than the S&P 500's daily gain of 0.06%. Elsewhere, the Dow saw an upswing of 0.17%, while the tech-heavy Nasdaq appreciated by 0.39%. Drug stock price rallies intensified following better-than-expected clinical trial success rates. Biogen (BIIB) hit $239.15, indicating market confidence in pipeline monetization.